JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
4726
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $104K | ﹤0.01% |
8,068
+893
| +12% | +$9.41K |
|
4727
Avantor
AVTR
$9.37B
| $103K | ﹤0.01% |
+5,536
| New | +$98.5K |
|
4728
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
| $103K | ﹤0.01% |
3,975
+3,900
| +5,200% | +$102K |
|
4729
e.l.f. Beauty
ELF
$5.43B
| $102K | ﹤0.01% |
7,207
-140,308
| -95% | -$1.7M |
|
4730
Energy Recovery
ERII
$399M
| $102K | ﹤0.01% |
10,203
-53,483
| -84% | -$526K |
|
4731
iShares Global 100 ETF
IOO
$9.46B
| $102K | ﹤0.01% |
2,100
| – | – |
|
4732
MasterCraft Boat Holdings
MCFT
$598M
| $102K | ﹤0.01% |
5,057
+558
| +12% | +$12.7K |
|
4733
Transcat
TRNS
$888M
| $102K | ﹤0.01% |
3,975
-558
| -12% | -$13.7K |
|
4734
VirnetX Holding Corp
VHC
$64.8M
| $102K | ﹤0.01% |
832
+120
| +17% | +$15K |
|
|
TGH
4735
DELISTED
Textainer Group Holdings limited
TGH
| $102K | ﹤0.01% |
10,535
+2,061
| +24% | +$20.3K |
|
4736
Gogo Inc
GOGO
$377M
| $101K | ﹤0.01% |
25,784
+3,918
| +18% | +$19K |
|
4737
PDF Solutions
PDFS
$2.13B
| $101K | ﹤0.01% |
7,764
+1,010
| +15% | +$13K |
|
4738
Regional Management Corp
RM
$301M
| $101K | ﹤0.01% |
3,986
-4,015
| -50% | -$100K |
|
|
RDNW
4739
RideNow Group
RDNW
$241M
| $101K | ﹤0.01% |
+1,169
| New | +$110K |
|
|
SEE
4740
PUT
DELISTED
Sealed Air
SEE
| $101K | ﹤0.01% |
2,400
+100
| +4% | +$4.4K |
|
|
AQ
4741
DELISTED
Aquantia Corp. Common Stock
AQ
| $101K | ﹤0.01% |
7,726
+2,470
| +47% | +$28.9K |
|
4742
Amerant Bancorp
AMTB
$1.14B
| $100K | ﹤0.01% |
5,314
+1,624
| +44% | +$28.6K |
|
4743
Biglari Holdings Class A
BH.A
$1.2B
| $100K | ﹤0.01% |
185
+25
| +16% | +$15.9K |
|
|
GOOS
4744
Canada Goose Holdings
GOOS
$850M
| $100K | ﹤0.01% |
2,676
-81,676
| -97% | -$3.68M |
|
|
CCXI
4745
DELISTED
ChemoCentryx, Inc.
CCXI
| $100K | ﹤0.01% |
11,191
+5,710
| +104% | +$66.1K |
|
4746
AC Immune
ACIU
$262M
| $99K | ﹤0.01% |
18,162
+3,113
| +21% | +$15.9K |
|
4747
Citizens
CIA
$198M
| $98K | ﹤0.01% |
13,588
+1,515
| +13% | +$10.4K |
|
4748
WisdomTree Europe SmallCap Dividend Fund
DFE
$169M
| $98K | ﹤0.01% |
1,700
| – | – |
|
|
FSTX
4749
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $98K | ﹤0.01% |
6,266
+1,641
| +35% | +$44K |
|
|
JCP
4750
DELISTED
J.C. Penney Company, Inc.
JCP
| $98K | ﹤0.01% |
89,659
+10,109
| +13% | +$12K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.